Skip to main content
. 2020 May 20;37(7):1737–1744. doi: 10.1007/s10815-020-01815-5

Table 1.

Clinical parameters of the adolescent transgender males

Subject Age (y) BMI (kg/m2) Length of time since the first period (y) Length of menstrual cycle (d) FSH (mIU/mL) LH (mIU/mL) E2 (pg/mL) T (nmole/L) TSH (μIU/mL) Prolactin (mIU/L) AFC (total number)
1 17 23.3 5 35 7.3 4.3 147 0.6 6.07 341 13
2 17 23.9 2 30 4.8 2.8 80 1.2 1.46 495 25
3 18 20.8 7 28 5.71 19.6 201 2.62 1.23 236 15
4 17 22.3 5 28 6.53 3.72 200 0.8 3.2 255 18
5 16 20 4 28 6.6 3 84 1.4 2.17 201 16
6 14 21.6 0.5 28 4.1 1.7 132 0.8 4.04 138 30
7 17 19 5 30 6.55 5.18 145 0.9 3.38 477 17
8 16 24.4 5 28 1.5 0.5 132 1 0.95 251 25
9 16 21.5 4 30 6.1 3.9 116 0.8 1.02 188 20
Mean (SD) 16.4 ± 1.1 21.8 ± 1.7 4.2 ± 1.9 29.4 ± 2.3 5.4 + 1.7 4.9 ± 5.6 137 ± 42 1.1 ± 0.6 2.6 ± 1.7 286 ± 125 19.8 ± 5.6

BMI body mass index, FSH follicle-stimulating hormone, LH luteinizing hormone, E2 estradiol, T total testosterone, TSH thyroid stimulating hormone, AFC antral follicle count, ND no data, SD standard deviation

Standard reference ranges: FSH 1–9.2 mIU/mL; LH 0.4–11.7 mIU/mL; E2 34–170 pg/mL; T 0.48–1.85 nmole/L; TSH 0.5–4.8 μIU/mL; prolactin 108.78–557.13 mIU/L